Literature DB >> 2856914

Tryptophan content of Clostridium perfringens epsilon toxin.

J Sakurai, M Nagahama.   

Abstract

The tryptophan content of Clostridium perfringens epsilon toxin was investigated. When the tryptophan content was determined by amino acid analysis after the hydrolysis of epsilon prototoxin with methanesulfonic acid containing 3-(2-aminoethyl)indole and by the spectrophotometric method with N-bromosuccinimide, the number of tryptophan residues was calculated at 1/mol of the protein. Cleavage of the prototoxin or the toxin with N-bromosuccinimide in the presence of urea gave two new fragments on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. There was only a tyrosine residue as the new N-terminal amino acid after the cleavage of the prototoxin or the toxin with N-bromosuccinimide. The data showed that epsilon prototoxin or epsilon toxin contained only one tryptophan residue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856914      PMCID: PMC261505          DOI: 10.1128/iai.47.1.260-263.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin.

Authors:  A S Bhown; A F Habeerb
Journal:  Biochem Biophys Res Commun       Date:  1977-10-10       Impact factor: 3.575

2.  Purification of beta-toxin from Clostridium perfringens type C.

Authors:  J Sakurai; C L Duncan
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

3.  Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.

Authors:  A F Habeeb; C L Lee; M Z Atassi
Journal:  Biochim Biophys Acta       Date:  1973-10-18

4.  Studies on epsilon-prototoxin of Clostridium perfringens type D. I. Purification methods: evidence for multiple forms of epsilon-prototoxin.

Authors:  A F Habeeb
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

5.  Sulfenyl halides as modifying reagents for polypeptides and proteins. I. Modification of tryptophan residues.

Authors:  E Scoffone; A Fontana; R Rocchi
Journal:  Biochemistry       Date:  1968-03       Impact factor: 3.162

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Separation of dansyl-amino acids by polyamide layer chromatography.

Authors:  K R Woods; K T Wang
Journal:  Biochim Biophys Acta       Date:  1967-02-21

8.  Complete amino acid analysis of proteins from a single hydrolysate.

Authors:  R J Simpson; M R Neuberger; T Y Liu
Journal:  J Biol Chem       Date:  1976-04-10       Impact factor: 5.157

9.  Studies on epsilon-prototoxin of Clostridium perfringens type D. Physicochemical and chemical properties of epsilon-prototoxin.

Authors:  A F Habeeb
Journal:  Biochim Biophys Acta       Date:  1975-11-18

10.  Selective chemical cleavage of tryptophanyl peptide bonds by oxidative chlorination with N-chlorosuccinimide.

Authors:  Y Shechter; A Patchornik; Y Burstein
Journal:  Biochemistry       Date:  1976-11-16       Impact factor: 3.162

View more
  3 in total

1.  High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain.

Authors:  M Nagahama; J Sakurai
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli.

Authors:  S E Hunter; I N Clarke; D C Kelly; R W Titball
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin.

Authors:  M Nagahama; Y Okagawa; T Nakayama; E Nishioka; J Sakurai
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.